Toxic erythema

L12_ERTYTH_TOXIC

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L53.0 Hospital discharge: ICD-9 — 6950A\|6951D Hospital discharge: ICD-8 — 69500 Cause of death: ICD-10 — L53.0 Cause of death: ICD-9 — 6950A\|6951D Cause of death: ICD-8 — 69500 2 out of 7 registries used, show all original rules.	68
4. Check minimum number of events None	68
5. Include endpoints None	68
6. Filter based on genotype QC (FinnGen only)	65

Control definitions (FinnGen only)

Control exclude: L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L53
Name in latin: Erythema toxicum

NAME	L12_ERTYTH_TOXIC
CONTROL_EXCLUDE	L12_URTICARIAERYTHEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L530
HD_ICD_9	6950A\|6951D
HD_ICD_8	69500
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L530
COD_ICD_9	6950A\|6951D
COD_ICD_8	69500
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Toxic erythema based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	643	346	293
Only index persons	480	272	208
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	41.77	45.18	37.64
Only index persons	35.89	39.71	30.89

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	65	46	19
Unadjusted period prevalence (%)	0.01	0.02	0.01
Median age at first event (years)	39.42	40.06	37.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
68: Matched controls
680

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L53.0

ICD-10 Finland

Toxic erythema

+∞

43.5

6951D

ICD-9 Finland

Erythematous conditions, Erythema multiforme[ERYTHEMA FIXUM]

+∞

17.4

69500

ICD-8 Finland

Erythematous condition, Toxic erythema

+∞

10.7

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026008) Bacteria identified in Urine by Culture

153

2.56

3.40

3.2

2.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

149

2.49

3.19

2.7

2.1

132.57

137.92

u/l

0.06

140

(3013139) Helicobacter pylori Ag [Presence] in Stool

3.86

2.83

2.0

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

5.86

2.60

1.0

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

221

2.20

2.58

2.4

2.3

69.59

76.43

nmol/l

1.18

199

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

5.36

2.46

1.0

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

103

2.33

2.37

1.7

1.6

0.58

0.88

mg/l

0.77

(3044889) 12 lead EKG panel

353

2.22

2.31

3.0

3.5

—

(3000494) Fungus identified in Specimen by Culture

2.58

2.26

1.1

1.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

162

2.11

2.19

3.4

3.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

5.30

2.11

1.2

1.0

—

(40768443) Skin Pathology biopsy report

3.59

2.02

1.4

1.2

—

(3045414) Leukocytes [Presence] in Urine

4.00

1.98

1.3

1.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.28

1.87

1.7

2.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

402

2.07

1.82

4.0

4.2

9.76

11.06

mm/h

0.36

373

(3022313) Gas panel - Capillary blood

3.55

1.79

1.8

3.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2.75

1.75

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

3.76

1.64

1.2

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3.19

1.62

2.0

0.98

1.68

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

3.03

1.54

2.0

1.9

24.58

25.07

mmol/l

—

(3022217) INR in Platelet poor plasma by Coagulation assay

217

1.79

1.50

10.5

12.2

1.20

inr

0.00

(40761535) Cells panel - Urine sediment

2.50

1.50

3.7

3.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

246

1.76

1.46

4.0

6.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

3.29

1.46

2.0

4.1

23.88

24.77

mmol/l

—

(3009508) Creatinine [Moles/volume] in Urine

140

1.84

1.44

2.6

2.7

6.75

7.64

mmol/l

0.24

110

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

537

2.32

1.42

17.4

13.0

22.22

20.33

mg/l

0.21

411

(3016879) Cocaine [Presence] in Urine

3.09

1.38

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

3.09

1.38

1.0

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3.09

1.38

2.2

2.1

0.90

0.77

—

(3023368) Bacteria identified in Blood by Culture

112

1.83

1.25

3.5

4.9

—

(3000764) Benzodiazepines [Presence] in Urine

2.76

1.24

1.2

1.3

—

(3028300) Cannabinoids [Presence] in Urine

2.76

1.24

1.2

1.3

—

(3027008) Opiates [Presence] in Urine

2.76

1.24

1.2

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

275

1.66

1.21

4.1

6.4

10.94

11.11

umol/l

0.05

263

(3030467) Casts [#/volume] in Urine by Automated count

130

1.76

1.20

3.0

2.7

0.01

0.52

e6/l

2.44

(3019309) Folate [Moles/volume] in Red Blood Cells

1.88

1.20

2.1

1.8

1650.32

1306.20

nmol/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

257

1.65

1.18

5.8

5.1

0.00

estimate

—

(3027944) Amphetamines [Presence] in Urine

2.61

1.17

1.2

1.3

—

(3012544) pH of Venous blood

2.08

1.13

2.8

—

(3000492) Spirometry study

2.08

1.13

1.3

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.88

1.08

2.3

2.5

0.15

0.85

e6/l

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.01

1.05

2.3

8.8

104.89

103.90

mmol/l

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.37

1.05

2.4

2.2

118.60

129.09

g/l

—

(3019225) pH of Specimen

1.96

1.03

3.9

5.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.00

1.03

1.5

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.00

1.03

1.4

1.9

—

(3009261) Glucose [Presence] in Urine by Test strip

265

1.57

1.00

4.6

3.8

0.00

estimate

—

(3022621) pH of Urine by Test strip

1.99

0.97

3.4

2.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1.97

0.91

1.6

2.2

9.41

9.94

g/l

—

(4200892) Spirometry reversibility

1.93

0.89

1.9

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

177

1.55

0.87

2.6

3.0

2.36

mmol/l

0.01

153

(36304419) Bacteria [Presence] in Urine

134

1.58

0.83

2.9

2.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.90

0.81

1.7

1.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

501

1.67

0.81

12.3

82.50

81.70

ml/min/173m2

0.09

392

(3018095) Leukocytes [#/volume] in Urine

171

1.52

0.80

3.4

3.7

82.88

80.20

e6/l

0.01

128

(3037467) Urinalysis macro (dipstick) panel - Urine

355

1.48

0.77

5.5

3.8

—

(40768797) Stomach Pathology biopsy report

1.74

0.77

1.1

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.74

0.77

5.1

7.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

119

1.57

0.76

4.2

3.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.67

0.75

2.4

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

202

1.46

0.73

2.2

1.9

115.23

101.68

pmol/l

0.44

(3035350) Ketones [Presence] in Urine by Test strip

260

1.44

0.71

4.6

3.7

0.00

estimate

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.64

0.63

2.3

1.5

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

556

1.67

0.62

18.5

15.1

72.50

74.29

umol/l

0.28

556

(3020682) Albumin/Creatinine [Ratio] in Urine

143

1.46

0.61

3.5

40.57

2.46

mg/mmol

0.99

(3013512) EKG study

154

1.42

0.57

5.2

3.2

—

(40768804) Tissue Pathology biopsy report

210

1.39

0.57

2.1

—

(3025941) Bacteria identified in Stool by Culture

1.63

0.56

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

107

0.61

0.54

1.3

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

514

0.72

0.52

4.3

3.8

1.35

1.25

mmol/l

0.36

470

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

117

0.64

0.51

1.8

2.1

—

(40761511) CBC panel - Blood by Automated count

560

1.61

0.51

16.6

11.7

—

(3002582) Erythrocytes [#/volume] in Urine

149

1.38

0.49

3.1

2.9

18.44

433.07

e6/l

0.51

121

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.46

0.48

2.2

1.7

—

(3012516) Albumin [Mass/volume] in Urine

132

1.38

0.46

2.8

2.9

125.38

16.64

mg/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.42

0.0

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

107

1.39

0.41

1.8

1.6

2.51

2.89

g/l

—

(3000991) Gas panel - Venous blood

1.51

0.41

2.6

9.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.42

0.40

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

358

1.28

0.40

3.3

3.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.46

0.40

1.2

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

409

1.30

0.40

6.0

4.1

14.94

14.62

pmol/l

0.41

371

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

526

0.76

0.39

4.8

4.3

5.58

5.84

mmol/l

1.97

485

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

192

1.30

0.39

5.9

3.3

62.55

28.07

ng/l

0.43

124

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.47

0.37

1.0

1.6

—

(21494755) Public health laboratory ask at order entry panel

1.39

0.32

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

149

1.28

0.32

5.9

3.8

0.00

estimate

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

499

1.28

0.30

6.7

4.7

1.75

1.85

mu/l

0.29

450

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

489

1.27

0.29

6.3

5.1

39.10

39.52

mmol/mol

0.12

461

(1761868) Lipid panel - Serum or Plasma

201

0.79

0.29

1.9

2.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

105

1.29

0.27

1.5

1.2

32.38

3.59

u/ml

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

125

1.26

0.25

1.3

1.2

1.20

0.74

u/ml

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

0.21

0.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.21

0.0

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.27

0.21

2.5

2.2

327.17

411.21

nmol/l

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.20

0.0

2.6

—

16.43

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.20

0.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.22

0.20

1.5

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

100

1.24

0.19

1.4

1.5

—

(3002256) Pathology report gross observation

1.21

0.19

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

209

1.15

0.16

5.4

3.7

—

(3003694) ABO and Rh group [Type] in Blood

133

1.16

0.13

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

533

1.17

0.13

4.3

4.74

4.78

mmol/l

0.11

497

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

536

1.14

0.09

4.4

4.7

2.88

2.79

mmol/l

0.23

494

(3042936) Bacteria identified in Isolate by Culture

0.84

0.08

1.7

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.08

0.08

1.6

—

(40758558) Short blood count panel - Blood

139

1.10

0.06

5.5

6.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

243

1.05

0.01

2.4

—

(3044640) Blood type and Crossmatch panel - Blood

165

0.96

0.00

1.9

2.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

531

0.99

0.00

4.3

1.54

mmol/l

0.04

491

(3041096) Erythrocytes [Presence] in Urine by Automated

146

1.04

0.00

4.6

3.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.00

0.00

4.6

3.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.2

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

-0.00

0.0

5.5

—

4.75

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

13.17

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

15.30

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.95

-0.00

1.7

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

2.3

—

(4062490) Immunoglobulin typing, IgG

0.00

-0.00

0.0

1.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

-0.00

0.0

2.4

—

495.14

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

2.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

3.9

—

177.86

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

-0.00

0.0

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.2

—

18.57

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

0.00

-0.00

0.0

2.6

—

9.60

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.0

—

2.00

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

-0.00

0.0

4.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.4

—

1976.60

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

-0.00

0.0

1.4

—

201.12

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

-0.00

0.0

1.2

—

42.12

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.2

—

31.60

—

(3017704) Immunofixation for Urine

0.00

-0.00

0.0

1.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

0.00

-0.00

0.0

3.0

—

84.00

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

5.4

—

(40768806) Pleura Pathology biopsy report

0.00

-0.00

0.0

1.8

—

(3045788) Cell count panel - Pleural fluid

0.00

-0.00

0.0

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

-0.00

0.0

13.8

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ERTYTH_TOXIC and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ERTYTH_TOXIC.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_ERTYTH_TOXIC – Toxic erythema

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Toxic erythema

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints